326 related articles for article (PubMed ID: 34996812)
1. Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma.
Liu B; Zhou Z; Jin Y; Lu J; Feng D; Peng R; Sun H; Mu X; Li C; Chen Y
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34996812
[TBL] [Abstract][Full Text] [Related]
2. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
3. Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma.
Chen Y; Qian B; Sun X; Kang Z; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y
Cancer Lett; 2021 Feb; 499():243-254. PubMed ID: 33246092
[TBL] [Abstract][Full Text] [Related]
4. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N
Nature; 2013 Jul; 499(7456):97-101. PubMed ID: 23803760
[TBL] [Abstract][Full Text] [Related]
5. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma.
Yamagishi R; Kamachi F; Nakamura M; Yamazaki S; Kamiya T; Takasugi M; Cheng Y; Nonaka Y; Yukawa-Muto Y; Thuy LTT; Harada Y; Arai T; Loo TM; Yoshimoto S; Ando T; Nakajima M; Taguchi H; Ishikawa T; Akiba H; Miyake S; Kubo M; Iwakura Y; Fukuda S; Chen WY; Kawada N; Rudensky A; Nakae S; Hara E; Ohtani N
Sci Immunol; 2022 Jun; 7(72):eabl7209. PubMed ID: 35749514
[TBL] [Abstract][Full Text] [Related]
6. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
7. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
8. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-361 suppresses the biological processes of hepatic stellate cells in HBV-relative hepatic fibrosis by NF-kappaB p65.
Yu G; Mu H; Zhou H; Fang F; Cui Y; Wu Q; Xiong Q; Li H
Cells Dev; 2021 Sep; 167():203711. PubMed ID: 34216805
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.
Liao R; Wu H; Yi Y; Wang JX; Cai XY; He HW; Cheng YF; Zhou J; Fan J; Sun J; Qiu SJ
J Exp Clin Cancer Res; 2013 Apr; 32(1):22. PubMed ID: 23601182
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
[TBL] [Abstract][Full Text] [Related]
13. Quiescent hepatic stellate cells induce toxicity and sensitivity to doxorubicin in cancer cells through a caspase-independent cell death pathway: Central role of apoptosis-inducing factor.
Das D; Fayazzadeh E; Li X; Koirala N; Wadera A; Lang M; Zernic M; Panick C; Nesbitt P; McLennan G
J Cell Physiol; 2020 Sep; 235(9):6167-6182. PubMed ID: 31975386
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17A educated hepatic stellate cells promote hepatocellular carcinoma occurrence through fibroblast activation protein expression.
Ni JS; Fu SY; Wang ZY; Ding WB; Huang J; Guo XG; Gu FM
J Gene Med; 2024 Jun; 26(6):e3693. PubMed ID: 38860366
[TBL] [Abstract][Full Text] [Related]
15. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma.
Nguyen PT; Kanno K; Pham QT; Kikuchi Y; Kakimoto M; Kobayashi T; Otani Y; Kishikawa N; Miyauchi M; Arihiro K; Ito M; Tazuma S
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3255-3268. PubMed ID: 32870388
[TBL] [Abstract][Full Text] [Related]
16. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
[TBL] [Abstract][Full Text] [Related]
17. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
[TBL] [Abstract][Full Text] [Related]
18. [Cellular senescence and chronic inflammation].
Ohtani N
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):390-7. PubMed ID: 25744638
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
